A geographically congruent "diabetes belt" with high prevalence of diabetes exists in the United States, according to a study published online March 8 in the American Journal of Preventive Medicine.
TUESDAY, March 8 (HealthDay News) -- A geographically congruent "diabetes belt" with high prevalence of diabetes exists in the United States, according to a study published online March 8 in the American Journal of Preventive Medicine.
Lawrence E. Barker, Ph.D., of the U.S. Centers for Disease Control and Prevention in Atlanta, and colleagues examined data from CDC estimates of diabetes prevalence to identify a diabetes belt. They compared its residents and their risk factors to those of the rest of the country, and calculated the fraction of excess diabetes risk associated with living in the diabetes belt that is attributable to modifiable and nonmodifiable risk factors. The diabetes belt was defined as counties in close proximity with an estimated prevalence of diagnosed diabetes greater than or equal to 11 percent.
The researchers identified a diabetes belt composed of 644 counties in 15 states, mostly in the southeastern United States. Compared to people living in the rest of the country, people in the diabetes belt were more likely to be non-Hispanic African-American, live a sedentary lifestyle, and be obese. Modifiable risk factors, such as sedentary lifestyle and obesity, accounted for 30 percent of the excess risk; whereas, 37 percent was due to nonmodifiable risk factors, such as age, gender, race/ethnicity, and education.
"Nearly one-third of the difference in diabetes prevalence between the diabetes belt and the rest of the United States is associated with sedentary lifestyle and obesity. Culturally appropriate interventions aimed at decreasing obesity and sedentary lifestyle in counties within the diabetes belt should be considered," the authors write.
Related Content
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More